Live · updated just now

Why gym-goers train may shape how they feel about performance drugs

Sunday, 8 November 2026 · Sports psychology & performance · Full report · Evidence: Limited

What was found

Gym-goers do not hold a single, sliding level of acceptance toward performance-enhancing drugs. Instead, their attitudes fall into seven distinct profiles, each shaped by different motives and ways of thinking 1. At one end are people who refuse such drugs on principle, guided by personal values. At the other end are people focused on performance who find reasons to justify use. Membership in certain profiles was weakly but measurably linked to having ever used anabolic steroids or testosterone replacement therapy. Growth hormone use did not differ meaningfully between the groups 1. The researchers concluded that attitudes toward doping are varied and cannot be captured by placing people on one scale from low to high risk.

Who it applies to

The findings concern recreational fitness and gym athletes in Germany 1. They do not necessarily describe competitive or professional athletes, or gym users in other countries.

How strong the evidence is

Early. This was a one-time online survey that grouped people by their answers using a statistical method called cluster analysis. The researchers also used written comments to illustrate each group 1. Of 624 people who took part, 550 were included in the analysis, and 52 gave open-ended responses. The seven groups were only modestly distinct from one another. When the analysis was rerun many times on resampled data, the groups held up only moderately well. Because the survey captured a single moment, it cannot show whether attitudes lead to drug use or the other way around. The authors caution against using the groups to label individual people 1. This summary is based on the abstract only, since the full article is not freely available.

What it means in practice

Efforts to reduce harm from performance-enhancing drugs in gyms may work better if messages are matched to different motivations. One general warning aimed at everyone may miss its mark 1. Someone who avoids drugs for ethical reasons may need little more than support for that choice. A person who rationalises use to improve results may respond better to frank, practical health information. Given the modest strength of the groupings, these profiles are best treated as a rough guide for planning messages rather than a precise sorting tool.

What others say

News coverage describes the study as a test of an earlier set of profiles developed by René Paasch and colleagues 2. The researchers checked whether that earlier typology would appear again in a separate group of athletes, and they added extra checks on how stable the results were 2.